HIV infection and COVID-19 death: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

Background: It is unclear whether HIV infection is associated with risk of COVID-19 death. We aimed to investigate this in a large-scale population-based study in England. Methods: Working on behalf of NHS England, we used the OpenSAFELY platform to analyse routinely collected electronic primary care data linked to national death registrations. People with a primary care record for HIV infection were compared to people without HIV. COVID-19 death was defined by ICD-10 codes U07.1 or U07.2 anywhere on the death certificate. Cox regression models were used to estimate the association between HIV infection and COVID-19 death, initially adjusted for age and sex, then adding adjustment for index of multiple deprivation and ethnicity, and finally for a broad range of comorbidities. Interaction terms were added to assess effect modification by age, sex, ethnicity, comorbidities and calendar time. Results: 17.3 million adults were included, of whom 27,480 (0.16%) had HIV recorded. People living with HIV were more likely to be male, of black ethnicity, and from a more deprived geographical area than the general population. There were 14,882 COVID-19 deaths during the study period, with 25 among people with HIV. People living with HIV had nearly three-fold higher risk of COVID-19 death than those without HIV after adjusting for age and sex (HR=2.90, 95% CI 1.96-4.30). The association was attenuated but risk remained substantially raised, after adjustment for deprivation and ethnicity (adjusted HR=2.52, 1.70-3.73) and further adjustment for comorbidities (HR=2.30, 1.55-3.41). There was some evidence that the association was larger among people of black ethnicity (HR = 3.80, 2.15-6.74, compared to 1.64, 0.92-2.90 in non-black individuals, p-interaction=0.045) Interpretation: HIV infection was associated with a markedly raised risk of COVID-19 death in a country with high levels of antiretroviral therapy coverage and viral suppression; the association was larger in people of black ethnicity.

[1]  B. Woodward,et al.  Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review , 2020, HIV medicine.

[2]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[3]  M. Davies HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. , 2020, medRxiv : the preprint server for health sciences.

[4]  Jessica K De Freitas,et al.  Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Babik,et al.  COVID-19 in Immunocompromised Hosts: What We Know So Far , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Hernán,et al.  Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy , 2020, Annals of Internal Medicine.

[7]  K. Khunti,et al.  The impact of ethnicity on clinical outcomes in COVID-19: A systematic review , 2020, EClinicalMedicine.

[8]  Noga Shalev,et al.  Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019 , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[9]  R. López-Vélez,et al.  Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort , 2020, The Lancet HIV.

[10]  F. Post,et al.  Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[11]  J. Sterne,et al.  Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.

[12]  Felipe García,et al.  COVID-19 in patients with HIV: clinical case series , 2020, The Lancet HIV.

[13]  S. Kenmoe,et al.  Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis , 2019, Journal of Clinical Virology.

[14]  C. Leen,et al.  Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study , 2017, The lancet. HIV.

[15]  Krishnan Bhaskaran,et al.  What is the difference between missing completely at random and missing at random? , 2014, International journal of epidemiology.

[16]  M. Poulton Patient confidentiality in sexual health services and electronic patient records , 2013, Sexually Transmitted Infections.

[17]  P. Peters,et al.  Influenza and HIV: Lessons from the 2009 H1N1 Influenza Pandemic , 2011, Current HIV/AIDS reports.

[18]  Melania Pintilie,et al.  Analysing and interpreting competing risk data , 2007, Statistics in medicine.

[19]  K. Neuzil,et al.  Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.

[20]  R. Rudd,et al.  Immunisation against infectious disease. , 1988, BMJ.

[21]  R. Evans European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).